# Kaye Mark: insider transactions

SEC CIK 1748691. Roles and transactions as reported on Form 4. Latest Form 4 filed 2026-10-23.

## Roles

| Company | Role | Transactions | First | Latest |
| --- | --- | ---: | --- | --- |
| [Elevance Health, Inc.](/companies/elv.md) | EVP & CFO, Officer | 13 | 2026-10-22 | 2026-10-22 |

## Transactions: 13

Every transaction reported, newest first. Codes P and S are open-market purchases and sales. Reported price is as stated on the form.

| Date | Company | Transaction | Shares | Reported price | Value | Filing |
| --- | --- | --- | ---: | ---: | ---: | --- |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 273 | $447.19 | $122.1k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 827 | $446.05 | $368.9k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 160 | $444.85 | $71.2k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 440 | $443.81 | $195.3k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 480 | $442.61 | $212.5k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 2,343 | $441.34 | $1.0m | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 1,720 | $440.44 | $757.6k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 1,160 | $439.25 | $509.5k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 240 | $438.22 | $105.2k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 560 | $437.07 | $244.8k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 1,660 | $436.20 | $724.1k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 321 | $435.25 | $139.7k | [Form 4](/filings/0001748691-26-000008.md) |
| 2026-10-22 | [Elevance Health, Inc.](/companies/elv.md) | Sale (S) | 400 | $434.00 | $173.6k | [Form 4](/filings/0001748691-26-000008.md) |

Source: SEC EDGAR, Forms 4. Last ingested by Listed: Oct 31, 2026, 21:19 ET. No prices; not investment advice.